Roivant Sciences Stock Total Debt
| ROIV Stock | USD 10.94 0.23 2.15% |
Roivant Sciences fundamentals help investors to digest information that contributes to Roivant Sciences' financial success or failures. It also enables traders to predict the movement of Roivant Stock. The fundamental analysis module provides a way to measure Roivant Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Roivant Sciences stock.
Total Debt To Capitalization is likely to climb to 0.11 in 2025. Roivant | Total Debt |
Roivant Sciences Company Total Debt Analysis
Roivant Sciences' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Roivant Sciences Total Debt | 499.75 M |
Most of Roivant Sciences' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Roivant Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Roivant Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Roivant Sciences is extremely important. It helps to project a fair market value of Roivant Stock properly, considering its historical fundamentals such as Total Debt. Since Roivant Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Roivant Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Roivant Sciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Roivant Total Debt Historical Pattern
Today, most investors in Roivant Sciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Roivant Sciences' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Roivant Sciences total debt as a starting point in their analysis.
Roivant Sciences Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Roivant Short Long Term Debt Total
Short Long Term Debt Total |
|
Based on the latest financial disclosure, Roivant Sciences has a Total Debt of 499.75 M. This is 81.83% lower than that of the Biotechnology sector and 53.87% higher than that of the Health Care industry. The total debt for all United States stocks is 90.6% higher than that of the company.
Roivant Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Roivant Sciences' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Roivant Sciences could also be used in its relative valuation, which is a method of valuing Roivant Sciences by comparing valuation metrics of similar companies.Roivant Sciences is currently under evaluation in total debt category among its peers.
Roivant Sciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Roivant Sciences from analyzing Roivant Sciences' financial statements. These drivers represent accounts that assess Roivant Sciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Roivant Sciences' important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 6.7B | 3.3B | 5.3B | 8.2B | 7.4B | 4.1B | |
| Enterprise Value | 4.9B | 1.5B | 4.1B | 2.1B | 1.9B | 2.1B |
Roivant Sciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Roivant Sciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Roivant Sciences' managers, analysts, and investors.Environmental | Governance | Social |
Roivant Sciences Institutional Holders
Institutional Holdings refers to the ownership stake in Roivant Sciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Roivant Sciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Roivant Sciences' value.| Shares | Amvescap Plc. | 2024-12-31 | 9.5 M | Geode Capital Management, Llc | 2024-12-31 | 7.8 M | Woodline Partners Lp | 2024-12-31 | 6.1 M | Toms Capital Investment Management Lp | 2024-12-31 | 5.9 M | Adage Capital Partners Gp Llc | 2024-12-31 | 5.7 M | Ubs Group Ag | 2024-12-31 | 5.3 M | Anchorage Advisors, Llc | 2024-12-31 | 4.8 M | Norges Bank | 2024-12-31 | 4.4 M | Blackbarn Capital Partners Lp | 2024-12-31 | 4.1 M | Qvt Financial Lp | 2024-12-31 | 65.8 M | Sb Investment Advisers (uk) Ltd | 2024-12-31 | 62.1 M |
Roivant Fundamentals
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | (0.95) % | ||||
| Operating Margin | (29.22) % | ||||
| Current Valuation | 2.6 B | ||||
| Shares Outstanding | 713.55 M | ||||
| Shares Owned By Insiders | 27.65 % | ||||
| Shares Owned By Institutions | 80.11 % | ||||
| Number Of Shares Shorted | 42.4 M | ||||
| Price To Book | 1.47 X | ||||
| Price To Sales | 63.16 X | ||||
| Revenue | 124.8 M | ||||
| Gross Profit | (469.54 M) | ||||
| EBITDA | 4.31 B | ||||
| Net Income | 4.23 B | ||||
| Cash And Equivalents | 1.94 B | ||||
| Cash Per Share | 2.76 X | ||||
| Total Debt | 499.75 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 6.20 X | ||||
| Book Value Per Share | 7.21 X | ||||
| Cash Flow From Operations | (765.27 M) | ||||
| Short Ratio | 11.17 X | ||||
| Earnings Per Share | (1.00) X | ||||
| Target Price | 16.0 | ||||
| Number Of Employees | 908 | ||||
| Beta | 1.26 | ||||
| Market Capitalization | 7.74 B | ||||
| Total Asset | 7.22 B | ||||
| Retained Earnings | 576.17 M | ||||
| Working Capital | 6.47 B | ||||
| Net Asset | 7.22 B |
About Roivant Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Roivant Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Roivant Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Roivant Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Roivant Stock Analysis
When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.